FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Register
horizonal rule

 

Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Food and Drug Administration Amendments Act of 2007 (FDAAA), enacted on September 27, 2007, added a new provision regarding financial conflicts of interest, § 712 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), effective October 1, 2007. Accordingly, for advisory committee meetings after October 1, 2007, FDA is granting waivers under 18 U.S.C. § 208 and § 712 of the FD&C Act, where applicable, when the relevant waiver standards in these statutes are met.

Waivers under 21 U.S.C. § 355(n)(4) were issued before October 1, 2007.  This provision was repealed, effective October 1, 2007, by the FDAAA.

Cardiovascular and Renal Drugs Advisory Committees

October 16, 2007

Nelson Watts, M.D.

  • 18 U.S.C. 208 waiver (pdf)
  • Acknowledgement and Consent (pdf)
  • 712 (c) (2) (B) waiver (pdf)
  • Acknowledgement of 712 (c) (2) (B) waiver (pdf)


 

Page updated: October 15, 2007

horizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Registers
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management
[Skip Navigation] link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page